Skip to main content
. Author manuscript; available in PMC: 2023 Sep 28.
Published in final edited form as: JAMA Netw Open. 2023 Apr 3;6(4):e239135. doi: 10.1001/jamanetworkopen.2023.9135

Figure 2.

Figure 2.

Solicited Local and Systemic Adverse Events

The percentage of participants in each treatment group with solicited local (A) and systemic (B) adverse events during the 7 days after each vaccination is plotted by US Food and Drug Administration toxicity grade, as any (mild, moderate, severe, or potentially life-threatening) or as grade 3 or higher (severe or potentially life-threatening).21